SEC
SlamSEC
SearchBrowseEarnings

FutureTech II Acquisition Corp.

FTII
Biological Products, (No Diagnostic Substances)·NEW ROCHELLE, NY
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

CEO
Chen Ray Lei
Revenue
—
Adj. EBITDA
—
Net Income
$2.9M
FY 2024
EPS (Diluted)
—
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$5,000
FY 2022
Total Debt
$2.9M
FY 2024
Net Debt
$2.9M
FY 2024
Enterprise Value
—
Debt / EBITDA
—
EV / EBITDA
—
Employees
—